Table 4 Evaluated screening strategies for breast cancer in women with a BRCA1/2/u mutation
Age (years) | Dutch strategy | UK strategy | US strategy |
|---|---|---|---|
25–30 | MRI every year | No screening | MRI and mammography every year |
30–50 | MRI and mammography every year | MRI and mammography every year | MRI and mammography every year |
50–60 | MRI and mammography every year | Mammography every 3 years in NBSP | MRI and mammography every year |
60–70 | Mammography every 2 years in NBSP | Mammography every 3 years in NBSP | MRI and mammography every year |
70–75 | Mammography every 2 years in NBSP | No screening | MRI and mammography every year |
Age over 75 when being in good health | No screening | No screening | MRI and mammography every year |
